Modongo C, Pasipanodya JG, Zetola NM, Williams SM, Sirugo G, Gumbo T.: Amikacin Concentrations Predictive of Ototoxicity in Multidrug-Resistant Tuberculosis Patients.
Antimicrob Agents Chemother. 59(10): 6337-43, Oct 2015 Notes:
Zetola NM, Macesic N, Shin SS, Peloso A, Ncube R, Klausner JD, Modongo C, Collman RG.: Erratum: Longer hospital stay is associated with high rates of tuberculosis-related morbidity and mortality within 12 months after discharge in a referral hospital in Sub-Saharan Africa.
BMC Infect Dis. 15: 211, May 2015
Shin SS, Modongo C, Ncube R, Sepako E, Klausner JD, Zetola NM: Advanced immune suppression is associated with increased prevalence of mixed-strain Mycobacterium tuberculosis infections among persons at high risk for drug-resistant tuberculosis in Botswana. The Journal of infectious diseases 211(3): 347-51, Feb 2015.
Zetola Nicola M, Shin Sanghyuk S, Tumedi Kefentse A, Moeti Keletso, Ncube Ronald, Nicol Mark, Collman Ronald G, Klausner Jeffrey D, Modongo Chawangwa: Mixed Mycobacterium tuberculosis complex infections and false-negative results for rifampin resistance by GeneXpert MTB/RIF are associated with poor clinical outcomes. Journal of clinical microbiology 52(7): 2422-9, Jul 2014.
Zetola Nicola M, Modongo Chawangwa, Moonan Patrick K, Ncube Ronald, Matlhagela Keikantse, Sepako Enoch, Collman Ronald G, Bisson Gregory P: Clinical outcomes among persons with pulmonary tuberculosis caused by Mycobacterium tuberculosis isolates with phenotypic heterogeneity in results of drug-susceptibility tests. The Journal of infectious diseases 209(11): 1754-63, Jun 2014.
Zetola NM, Modongo C, Olabiyi B, Ramogola-Masire D, Collman RG, Chao Li-Wei: Examining the relationship between alcohol use and high-risk sex practices in a population of women with high HIV incidence despite high levels of HIV-related knowledge. Sexually transmitted infections 90(3): 216-22, May 2014.
Modongo Chawangwa, Sobota Rafal S, Kesenogile Boikobo, Ncube Ronald, Sirugo Giorgio, Williams Scott M, Zetola Nicola M: Successful MDR-TB treatment regimens including amikacin are associated with high rates of hearing loss. BMC infectious diseases 14: 542, 2014.
Zetola NM, Macesic N, Modongo C, Shin S, Ncube R, Collman RG: Longer hospital stay is associated with higher rates of tuberculosis-related morbidity and mortality within 12 months after discharge in a referral hospital in Sub-Saharan Africa. BMC infectious diseases 14: 409, 2014.
Hafkin, J., Modongo, C., Newcomb, C., Lowenthal, E., Macgregor, R.R., Steenhoff, A.P., Friedman, H., Bisson, G.P.: Impact of the human immunodeficiency virus on early multidrug-resistant tuberculosis treatment outcomes in Botswana.
Int J Tuberc Lung Dis 17(3): 348-53, Mar 2013
Ncube, R., Agegnehu, D., Letebele, M., Gasennelwe, B., Bafetanye, M., Mahloane, D., Matome, M., Modongo, C., Phumaphi, O., Lanje, S., Makombe, R.: Botswana Public Private Mix Framework for Tuberculosis Control Department of Public Health, Botswana National Tuberculosis Control Program Dec 2012.
back to top
Last updated: 11/03/2015
The Trustees of the University of Pennsylvania